A comparison between the Bowel Ultrasound Score and International Bowel Ultrasound Segmental Activity Score based on ileocolonoscopy in patients with Crohn's disease.

IF 2.3 4区医学 Q3 GASTROENTEROLOGY & HEPATOLOGY

European Journal of Gastroenterology & Hepatology Pub Date : 2025-06-01 Epub Date: 2025-03-18 DOI:10.1097/MEG.0000000000002969

Ilhami Yuksel, Yavuz Cagir, Muhammed Bahaddin Durak, Ali Atay, Mucahit Ergul, Oguz Ozturk, Emir Tugrul Keskin, Ahmet Burak Fedai, Muhammed Mustafa Ince, Erdogan Deniz, Zeki Mesut Yalin Kilic

{"title":"A comparison between the Bowel Ultrasound Score and International Bowel Ultrasound Segmental Activity Score based on ileocolonoscopy in patients with Crohn's disease.","authors":"Ilhami Yuksel, Yavuz Cagir, Muhammed Bahaddin Durak, Ali Atay, Mucahit Ergul, Oguz Ozturk, Emir Tugrul Keskin, Ahmet Burak Fedai, Muhammed Mustafa Ince, Erdogan Deniz, Zeki Mesut Yalin Kilic","doi":"10.1097/MEG.0000000000002969","DOIUrl":null,"url":null,"abstract":"Background and aim: We aimed to compare two main existing scores, the Bowel Ultrasound Score (BUSS) and the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to predict simplified endoscopic activity score for Crohn's disease (SES-CD).Methods: A cross-sectional study was conducted to evaluate the disease activity in Crohn's disease (CD) patients with ileal involvement between November 2019 and February 2024. Endoscopic remission for CD was accepted as SES-CD ≤2.Results: A total of 56 adult patients with CD (male: 38, 68%, median age: 40.5 years) were included in the study, the median duration of the disease was 8.4 years. The cutoff value for BUSS to determine endoscopic remission was 3.9, whereas the cutoff value for IBUS-SAS to establish endoscopic remission was 24.4. BUSS and SES-CD had a strong positive correlation ( P < 0.001), BUSS and IBUS-SAS had a high positive correlation ( P < 0.001), and BUSS and C-reactive protein had a slightly positive correlation ( P < 0.001).Conclusion: This study revealed that the cutoff values for BUSS and IBUS-SAS in CD patients with endoscopic remission were 3.9 and 24.4, respectively. Furthermore, it was demonstrated that BUSS and IBUS-SAS highly correlate with endoscopic activity in the real-world cohort.","PeriodicalId":11999,"journal":{"name":"European Journal of Gastroenterology & Hepatology","volume":" ","pages":"710-716"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MEG.0000000000002969","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and aim: We aimed to compare two main existing scores, the Bowel Ultrasound Score (BUSS) and the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to predict simplified endoscopic activity score for Crohn's disease (SES-CD).

Methods: A cross-sectional study was conducted to evaluate the disease activity in Crohn's disease (CD) patients with ileal involvement between November 2019 and February 2024. Endoscopic remission for CD was accepted as SES-CD ≤2.

Results: A total of 56 adult patients with CD (male: 38, 68%, median age: 40.5 years) were included in the study, the median duration of the disease was 8.4 years. The cutoff value for BUSS to determine endoscopic remission was 3.9, whereas the cutoff value for IBUS-SAS to establish endoscopic remission was 24.4. BUSS and SES-CD had a strong positive correlation ( P < 0.001), BUSS and IBUS-SAS had a high positive correlation ( P < 0.001), and BUSS and C-reactive protein had a slightly positive correlation ( P < 0.001).

Conclusion: This study revealed that the cutoff values for BUSS and IBUS-SAS in CD patients with endoscopic remission were 3.9 and 24.4, respectively. Furthermore, it was demonstrated that BUSS and IBUS-SAS highly correlate with endoscopic activity in the real-world cohort.

查看原文本刊更多论文

基于回肠结肠镜检查的肠超声评分与国际肠超声节段活动评分在克罗恩病患者中的比较

背景和目的：我们旨在比较两个主要的现有评分，肠超声评分（BUSS）和国际肠超声节段活动评分（IBUS-SAS），以预测克罗恩病（SES-CD）的简化内镜活动评分。方法：通过横断面研究评估2019年11月至2024年2月期间克罗恩病（CD）回肠受累患者的疾病活动性。内镜下CD缓解为SES-CD≤2。结果：共纳入56例成年CD患者（男性38例，68%，中位年龄40.5岁），中位病程8.4年。BUSS确定内镜下缓解的截止值为3.9，而IBUS-SAS确定内镜下缓解的截止值为24.4。结论：本研究显示，内镜下缓解的CD患者的BUSS和IBUS-SAS的临界值分别为3.9和24.4。此外，研究表明，在现实世界的队列中，BUSS和IBUS-SAS与内窥镜活动高度相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Gastroenterology & Hepatology 医学-胃肠肝病学

CiteScore

4.40

自引率

4.80%

发文量

269

审稿时长

1 months

期刊介绍： European Journal of Gastroenterology & Hepatology publishes papers reporting original clinical and scientific research which are of a high standard and which contribute to the advancement of knowledge in the field of gastroenterology and hepatology. The journal publishes three types of manuscript: in-depth reviews (by invitation only), full papers and case reports. Manuscripts submitted to the journal will be accepted on the understanding that the author has not previously submitted the paper to another journal or had the material published elsewhere. Authors are asked to disclose any affiliations, including financial, consultant, or institutional associations, that might lead to bias or a conflict of interest.